This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2018-02-09 CDAMG Conference Call"

From HL7Wiki
Jump to navigation Jump to search
(Created page with "back to [http://wiki.hl7.org/index.php?title=CDA_Management_Group CDA Management Group main page] {|border="1" cellpadding="2" cellspacing="0" <!---==========================...")
 
Line 12: Line 12:
 
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 CDAMG Minutes''' <br/>
 
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 CDAMG Minutes''' <br/>
 
'''Location: ''' Pelican - Riverside Bldg.
 
'''Location: ''' Pelican - Riverside Bldg.
| colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2018-01-29'''<br/> '''Time: 3:30 PM'''
+
| colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2018-02-09'''<br/> '''Time: 2:00 PM (ET)'''
 
|-
 
|-
 
| colspan="1" align="right"|'''Facilitator'''
 
| colspan="1" align="right"|'''Facilitator'''
Line 24: Line 24:
 
{|border="1" cellpadding="2" cellspacing="0"  
 
{|border="1" cellpadding="2" cellspacing="0"  
 
| border="1" cellpadding="2" colspan="1" align="left"|'''Attendee'''
 
| border="1" cellpadding="2" colspan="1" align="left"|'''Attendee'''
| '''Name'''
 
 
 
<!---==============================================================================
 
|                                                                                |
 
|    AAAA  TTTTTT  TTTTTT  EEEEEE  NN    NN  DDDDD    EEEEEE  EEEEEE  SSSSS    |
 
|  AA  AA    TT      TT    EE      NNN  NN  DD  DD  EE      EE      SS        |
 
|  AAAAAA    TT      TT    EEEE    NN NN NN  DD  DD  EEEE    EEEE    SSSS      |
 
|  AA  AA    TT      TT    EE      NN  NNN  DD  DD  EE      EE          SS    |
 
|  AA  AA    TT      TT    EEEEEE  NN    NN  DDDDD    EEEEEE  EEEEEE  SSSSS      |
 
|                                                                                |
 
===============================================================================--->
 
 
|-
 
| X|| George Dixon
 
|-
 
| X||Jean Duteau
 
|-
 
| X|| Rick Geimer
 
|-
 
| X|| Kai Heitmann
 
|-
 
| X|| Brett Marquard
 
|-
 
| X|| Linda Michaelsen
 
|-
 
| X|| Dale Nelson
 
|-
 
| X|| Lisa Nelson
 
|-
 
| X|| Andrew Statler
 
|-
 
|colspan="4" style="background:#f0f0f0;"|
 
|-
 
|colspan="4" style="font-style:italic; color:green;" |''Quorum: Chair +3''
 
 
|}
 
<!---=======================================================
 
|                                                          |
 
|    AAAA    GGGGG  EEEEEE  NN    NN  DDDDD    AAAA      |
 
|  AA  AA  GG      EE      NNN  NN  DD  DD  AA  AA    |
 
|  AAAAAA  GG  GGG  EEEE    NN NN NN  DD  DD  AAAAAA    |
 
|  AA  AA  GG  GG  EE      NN  NNN  DD  DD  AA  AA    |
 
|  AA  AA  GGGGG  EEEEEE  NN    NN  DDDDD    AA  AA    |
 
|                                                          |
 
========================================================--->
 
===Agenda & Minutes===
 
* Welcome Guests: Cynthia Canteen Harbor (CDC NHSN), Russel Ott (VA)
 
*Agenda review
 
*Approve Minutes of [[2018-01-05_CDAMG_Conference_Call]]
 
*Review items
 
**[http://wiki.hl7.org/images/6/6e/HL7_Project_Scope_Statement_Orthodontic_Attachment_v03.docx Orthodontic Attachment PSS]
 
*Discussion Topics
 
**Asset - Status, and ongoing management.
 
**SWOT
 
*** Reviewed the SWOT drafted in SDWG earlier in the day
 
*** Generalized the SWOT to make it less US Specific
 
*** Does the CMG Scope cover the HL7 Affiliates or not?
 
*** Could we review the SWOT more frequently
 
**What are the requirements of a CDA Templates Registry - prep Tuesday Q4 discussion
 
**Discuss the envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
 
*** CMG will revisit this issue in the context of the Product Roadmap. 
 
*** Jean asked:  What is the expectation for CDA R2.0 after CDA R2.1 is released?
 
*** Linda asked: What happens to C-CDA if CDA R2.0 is superceeded by R2.1
 
**Create a check list procedure for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
 
*** Why should CMG get inserted so late in the process.  Should we aim to get involved sooner - at the NIB - to approve when things get started.  From a quality perspective - should we be injected sooner. At the NIB, could we get involved then. When is the right time?  Maybe two weeks prior to preliminary content has to come to CMG to review the work.  CMG is responsible for making sure that the sponsoring workgroup is the primary check of the QA criteria, then CMG reviews to make sure the Workgroup has enforced the QA criteria accurately.  Key is:  Is this work a duplicate?  Is it being done by the right group?  Are produced artifacts meeting the defined quality.
 
*** Should we push back and not have CMG be a step in the review process? We want to be a check box on the Publication Request to show that we have done the review with the submitting party. Injected Andrew/Rick [0-0-8] Approved.
 
** George Asked:  How do we manage quality problems for IG's that have already been publishes?  We agreed to add this to the Weakness list in SWOT.
 
** Russ Ott presented a new PSS for Orthodontic Claims Attachment IG. Positioned as "based on C-CDA R2.1" It is subordinate under the Claims Attachment IG. This project is sponsored under the Attachments WG. "Inspired by the DOD as the "document receiver". Document creator would be a Dental EMR. 2-year STU. Russ will check with IHE Dental Domain to see what has been done there. Russ will get DOD to sign on as an implementer. Payer organization could be.  Rick/Jean [0-0-8] Approved.
 
 
 
 
===Meeting Outcomes===
 
{|border="1" cellpadding="2" cellspacing="0"
 
|-
 
<!---==============================================================
 
|                                                                |
 
|    AAAA    CCCCC  TTTTTT  IIIIII  OOOOO  NN    NN  SSSSS    |
 
|  AA  AA  CC        TT      II    OO  OO  NNN  NN  SS        |
 
|  AAAAAA  CC        TT      II    OO  OO  NN NN NN  SSSS      |
 
|  AA  AA  CC        TT      II    OO  OO  NN  NNN      SS    |
 
|  AA  AA  CCCCC    TT    IIIIII  OOOOO  NN    NN  SSSSS      |
 
|                                                                |
 
===============================================================--->
 
 
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
 
*
 
 
|-
 
<!---=======================================================================
 
|                                                                          |
 
|  NN    NN  EEEEEE  XX  XX  TTTTTT      MM    MM  TTTTTT  GGGGG      |
 
|  NNN  NN  EE      XX XX    TT        MMM  MMM    TT    GG          |
 
|  NN NN NN  EEEE      XXX      TT        MM MMM MM    TT    GG  GGG    |
 
|  NN  NNN  EE      XX XX    TT        MM  M  MM    TT    GG  GG    |
 
|  NN    NN  EEEEEE  XX  XX    TT        MM    MM    TT    GGGGG      |
 
|                                                                          |
 
========================================================================--->
 
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
*[[TBD]]
 
 
|}
 
 
© 2017 Health Level Seven® International.  All rights reserved
 
 
| '''Name'''
 
| '''Name'''
  
Line 155: Line 50:
 
| || Linda Michaelsen
 
| || Linda Michaelsen
 
|-
 
|-
||| Dale Nelson
+
| || Dale Nelson
 
|-
 
|-
 
| || Lisa Nelson
 
| || Lisa Nelson
Line 175: Line 70:
 
|                                                          |
 
|                                                          |
 
========================================================--->
 
========================================================--->
===Agenda===
+
===Agenda & Minutes===
 +
* Welcome
 
*Agenda review
 
*Agenda review
*Approve Minutes of [[2018-01-05_CDAMG_Conference_Call]]
+
*Approve Minutes of [[2018-01-29_CDAMG_WGM]]
 
*Review items
 
*Review items
**[http://wiki.hl7.org/images/6/6e/HL7_Project_Scope_Statement_Orthodontic_Attachment_v03.docx Orthodontic Attachment PSS]
+
**[http://wiki.hl7.org/images/c/c7/20180208_HL7_PSS_CDA_XSL_Update_for_CDA_Release_2-1.docx CDA R2.1 Style Sheet Creation PSS]
 
*Discussion Topics
 
*Discussion Topics
**Asset - Status, and ongoing management.
+
 
 
**SWOT
 
**SWOT
**What are the requirements of a CDA Templates Registry - prep Tuesday Q4 discussion
+
*** Reviewed the SWOT
**Discuss the envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
+
*** Any updates as a result of activity at the WGM?
**Create a check list procedure for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
+
*** Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT.
 
+
**Asset List - Status, and ongoing management.
===Minutes===
+
***Discuss Status/Development toward CDA Template Interchage Format
 +
***Discuss Status of CDA Template Registry  
 +
**Discuss need for & Development of overall CDA Product Roadmap
 +
**** Roadmap needs to address questions like: 
 +
*** Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
 +
*** Expectation for CDA R2.0 after CDA R2.1 is released?
 +
*** What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
 +
** Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
 +
*** Review minutes from 2018-01-29.
 +
*** Is our plan sufficiently clear and actionable?  Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
 +
** Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)
  
  

Revision as of 14:42, 9 February 2018

back to CDA Management Group main page

HL7 CDAMG Minutes

Location: Pelican - Riverside Bldg.

Date: 2018-02-09
Time: 2:00 PM (ET)
Facilitator Brett Note taker(s) Lisa
Attendee Name


George Dixon
Jean Duteau
Rick Geimer
Kai Heitmann
Brett Marquard
Linda Michaelsen
Dale Nelson
Lisa Nelson
Andrew Statler
Quorum: Chair +3

Agenda & Minutes

    • SWOT
      • Reviewed the SWOT
      • Any updates as a result of activity at the WGM?
      • Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT.
    • Asset List - Status, and ongoing management.
      • Discuss Status/Development toward CDA Template Interchage Format
      • Discuss Status of CDA Template Registry
    • Discuss need for & Development of overall CDA Product Roadmap
        • Roadmap needs to address questions like:
      • Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
      • Expectation for CDA R2.0 after CDA R2.1 is released?
      • What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
    • Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
      • Review minutes from 2018-01-29.
      • Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
    • Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)


Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items

© 2017 Health Level Seven® International. All rights reserved